Sign inJoin waitlistJoin the waitlist

Anne Chang

Director of Adult Dermatological Clinical Trials, Stanford Dermatology · Stanford Health Care

Credentials: · · ·

History

Stanford University
2010–2011
Stanford University
2009–2010
Ophthalmology
Stanford Health Care
2006–2009
Dermatology
Stanford University Dept of Dermatology (2007) CA
2003–2007
Santa Clara Valley Healthcare
2002–2004
University of California-San Francisco
1999–2002
Harvard Medical School
1995–1999
Harvard College
1991–1995

Research

Clonal replacement of tumor-specific T cells following PD-1 blockade
Nature Medicine · 2019 · 1,269 citations
Efficacy and safety of vismodegib in advanced basal-cell carcinoma
New England Journal of Medicine · 2012 · 1,139 citations
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
New England Journal of Medicine · 2018 · 1,114 citations

Anthony Oro
17 papers
Michael Migden
17 papers
KL
Karl Lewis
16 papers
Kavita Sarin
12 papers
Jean Tang
11 papers
AS
Aleksandar Sekulic
9 papers
Dimitrios Colevas
9 papers
GZ
Gefei Zhu
9 papers · 6 as a resident
MF
Matthew Fury
9 papers
DT
Duy Tran
8 papers
Howard Chang
8 papers
IL
Israel Lowy
8 papers

Clinical trials

Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy
Principal investigator · Active not recruiting · Phase 1, Phase 2
Stanford University
2024–2026
Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea
Principal investigator · Completed · Phase 1, Phase 2
Anne Chang
2017–2019
Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy Volunteers
Principal investigator · Completed · Phase 1
Anne Chang
2017–2019
Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer
Principal investigator · Completed · Phase 1, Phase 2
Anne Chang
2016–2018